No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia

M.L. Grijsen; R Holman; L. Gras; F.W. Wit; A.I.M. Hoepelman; G.E. van den Berk; F. de Wolf; J.M. Prins

No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia

Translated title of the contribution: No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia

M.L. Grijsen, R Holman, L. Gras, F.W. Wit, A.I.M. Hoepelman, G.E. van den Berk, F. de Wolf, J.M. Prins

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia
Original language	Undefined/Unknown
Pages (from-to)	1609-1613
Number of pages	14
Journal	Antiviral Therapy
Volume	17
Issue number	8
Publication status	Published - 2012

Cite this

@article{09822278d1b347d9a18bf0648f835b10,

title = "No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia",

author = "M.L. Grijsen and R Holman and L. Gras and F.W. Wit and A.I.M. Hoepelman and \{van den Berk\}, G.E. and \{de Wolf\}, F. and J.M. Prins",

year = "2012",

language = "Undefined/Unknown",

volume = "17",

pages = "1609--1613",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

number = "8",

}

TY - JOUR

T1 - No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia

AU - Grijsen, M.L.

AU - Holman, R

AU - Gras, L.

AU - Wit, F.W.

AU - Hoepelman, A.I.M.

AU - van den Berk, G.E.

AU - de Wolf, F.

AU - Prins, J.M.

PY - 2012

Y1 - 2012

M3 - Article

SN - 1359-6535

VL - 17

SP - 1609

EP - 1613

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 8

ER -